{"version":"1.0","type":"link","title":"Is EGFR back? ADCs revive targeted therapy in nasopharyngeal carcinoma.","author_name":"Kanemura H 외","author_url":"https://prs-insight.online/author/Kanemura%20H","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/76297","thumbnail_width":1200,"thumbnail_height":630}